To conduct microbiological analysis, at least three dry swabs (
MASTASWAB TM, Mast Group Ltd., Bootle, UK) were taken directly from the removed implant, the interface, and from macroscopically suspicious areas of the wound. The swabs were streaked out on Columbia agar with 5% sheep blood,
chocolate agar,
MacConkey agar, and
thioglycolate broth (bioMerieux, Hazelwood, MO, USA). Samples were then incubated at 37 °C in 5% CO
2 or anaerobic conditions for 48 h for short-term culturing; morphologically distinct colonies were identified and antibiotic susceptibility to 28 antibiotics was determined using the
Vitek2-machine (bioMerieux, Hazelwood, MO, USA) with standardized definition of minimum inhibitory concentration (MIC) and multi-drug resistance [14 (
link)]. At least two tissue samples from the interface, non-union, or macroscopically suspicious areas were directly inserted into a sterile containment prefilled with 9 ml of
thioglycolate broth (bioMerieux, Hazelwood, MO, USA). After incubation at 37 °C in 5% CO
2 or under anaerobic conditions for at least 14 days (long-term culturing), the suspension was additionally streaked out and proceeded as described above.
Kellermann F., Hackl S., Leister I., Hungerer S., Militz M., Stuby F., Holzmann B, & Friederichs J. (2023). Advances in the Treatment of Implant-Associated Infections of the Pelvis: Eradication Rates, Recurrence of Infection, and Outcome. Journal of Clinical Medicine, 12(8), 2854.